Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Terminated 1 Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 3 Brain Neoplasms 3 Radiation Pneumonitis 1 Radiation Injuries 1 Prostatic Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Optic Neuritis 1 Neoplasms, Fibrous Tissue 1 Neoplasms, Connective and Soft Tissue 1 Neoplasms, Connective Tissue 1 Neoplasms by Histologic Type 1 Neoplasm Metastasis 1 Myelitis, Transverse 1 Myelitis 1 Myasthenia Gravis 1 Musculoskeletal Diseases 1 Lung Neoplasms 1 Lung Diseases, Interstitial 1 Joint Diseases 1 Glioma 1 Fibroma 1 Dupuytren Contracture 1 Contracture 1 Connective Tissue Diseases 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Magnetic Resonance Spectroscopy 51 Specimen Handling 42 enzalutamide 35 Androgen Antagonists 34 Radiosurgery 32 Radiotherapy 31 Prednisone 26 darolutamide 24 Abiraterone Acetate 24 Leuprolide 22 Docetaxel 22 apalutamide 20 Pluvicto 19 abiraterone 18 Standard of Care 18 Triptorelin Pamoate 17 Radiation 17 Biopsy 16 relugolix 15 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 15 Goserelin 14 Blood Specimen Collection 13 gallium 68 PSMA-11 12 pembrolizumab 11 X-Rays 11 Surveys and Questionnaires 11 luprolide acetate gel depot 10 Carboplatin 10 Methods 9 Interviews as Topic 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Prostatic Neoplasms × Adrenal Cortex Hormones × Clear all

NCT06925737 2026-05-22

MK-2400-001

Merck Sharp & Dohme LLC

Phase 3 Recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡